Lead Product(s) : Mosedipimod
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Preclinical
Sponsor : NASA
Deal Size : $0.1 million
Deal Type : Funding
Details : NASA’s Human Research Program has awarded $150K in grant funding to conduct research on its lead compound EC-18, and how it impacts astronaut health and performance during future long-duration missions beyond low-Earth orbit.
Brand Name : EC-18
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 26, 2021
Lead Product(s) : Mosedipimod
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Preclinical
Sponsor : NASA
Deal Size : $0.1 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?